ATLANTA, May 25, 2011 /PRNewswire/ -- XDATA retains Adapt IP Ventures to market XDATA's intellectual property including patents and fully-functioning prototype focused on breast cancer detection. Over many decades, XDATA has developed, patented and tested methods and devices for automatically capturing and combining ultrasound and X-ray mammography images. As validation of the value of XDATA's patents, leading companies and research hospitals including GE, Hologic, U-Systems and The General Hospital Corporation have cited these patents in their own inventions.
"We are very excited about our partnership with XDATA," comments Adapt IP Ventures' CEO Grant Moss. "With over 180,000 new cases of breast cancer that are diagnosed each year, resulting in 40,000 or more deaths, there is an urgent and immediate need in the industry for a more effective screening tool."
"XDATA's pioneering combination of 3-D ultrasound and traditional mammography is clinically proven to offer improved sensitivity in screening even the most challenging and early cancers. Automatically capturing these images reduces impact on both doctor's time and unit cost," states John Brownlee, Evince's President and Founder and technical advisor to Adapt IP Ventures. "We have worked with many image technologies, but few are truly saving thousands of lives simultaneously with precious health care dollars. XDATA's patented solution is precisely that unique combination."
"Adapt IP Ventures and Evince will play a critical role in getting our patented technology out to the market," said Kris Dines, Ph.D., President and Founder of XDATA. "We look forward to broad industry adoption of our technology through the channels of a market leading company."
For more information, contact Grant Moss at email@example.com , +1-770-353-0756.
About XDATA Corporation
XDATA Corporation (www.xdatar